JP2014518557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014518557A5 JP2014518557A5 JP2014506615A JP2014506615A JP2014518557A5 JP 2014518557 A5 JP2014518557 A5 JP 2014518557A5 JP 2014506615 A JP2014506615 A JP 2014506615A JP 2014506615 A JP2014506615 A JP 2014506615A JP 2014518557 A5 JP2014518557 A5 JP 2014518557A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- vaccine
- virus
- immunogen
- silk fibroin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 46
- 230000002238 attenuated effect Effects 0.000 claims description 13
- 108010022355 Fibroins Proteins 0.000 claims description 12
- 229960005486 vaccine Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 244000052769 pathogen Species 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 208000037386 Typhoid Diseases 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 201000008297 typhoid fever Diseases 0.000 claims description 5
- 230000003612 virological effect Effects 0.000 claims description 3
- 201000005505 Measles Diseases 0.000 claims description 2
- 208000005647 Mumps Diseases 0.000 claims description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 2
- 208000010805 mumps infectious disease Diseases 0.000 claims description 2
- 201000005404 rubella Diseases 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims 17
- 230000002163 immunogen Effects 0.000 claims 14
- 241000894006 Bacteria Species 0.000 claims 10
- 229940032046 DTaP vaccine Drugs 0.000 claims 6
- 239000013543 active substance Substances 0.000 claims 5
- 230000001580 bacterial effect Effects 0.000 claims 5
- 229960003971 influenza vaccine Drugs 0.000 claims 5
- 239000011159 matrix material Substances 0.000 claims 4
- 241000991587 Enterovirus C Species 0.000 claims 3
- 241000701806 Human papillomavirus Species 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 241000606768 Haemophilus influenzae Species 0.000 claims 2
- 241000700721 Hepatitis B virus Species 0.000 claims 2
- 229940124726 Japanese encephalitis vaccine Drugs 0.000 claims 2
- 229940124859 Rotavirus vaccine Drugs 0.000 claims 2
- 229940032047 Tdap vaccine Drugs 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 230000004071 biological effect Effects 0.000 claims 2
- 239000002131 composite material Substances 0.000 claims 2
- 239000000835 fiber Substances 0.000 claims 2
- 208000002672 hepatitis B Diseases 0.000 claims 2
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 claims 2
- 229940124724 hepatitis-A vaccine Drugs 0.000 claims 2
- 229940124736 hepatitis-B vaccine Drugs 0.000 claims 2
- 239000000017 hydrogel Substances 0.000 claims 2
- 206010022000 influenza Diseases 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 2
- 239000002105 nanoparticle Substances 0.000 claims 2
- 244000309711 non-enveloped viruses Species 0.000 claims 2
- 229940124733 pneumococcal vaccine Drugs 0.000 claims 2
- 229960001539 poliomyelitis vaccine Drugs 0.000 claims 2
- 229960003127 rabies vaccine Drugs 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 239000010409 thin film Substances 0.000 claims 2
- 239000003053 toxin Substances 0.000 claims 2
- 231100000765 toxin Toxicity 0.000 claims 2
- 108700012359 toxins Proteins 0.000 claims 2
- 239000013603 viral vector Substances 0.000 claims 2
- 229940124965 ACAM2000 Drugs 0.000 claims 1
- 229940124962 ActHIB Drugs 0.000 claims 1
- 229940124963 Afluria Drugs 0.000 claims 1
- 241000193738 Bacillus anthracis Species 0.000 claims 1
- 101100394745 Bacillus subtilis (strain 168) hepT gene Proteins 0.000 claims 1
- 229940124899 Biothrax Drugs 0.000 claims 1
- 229940124900 Boostrix Drugs 0.000 claims 1
- 241000588832 Bordetella pertussis Species 0.000 claims 1
- 201000006082 Chickenpox Diseases 0.000 claims 1
- 229940124888 DECAVAC Drugs 0.000 claims 1
- 229940124902 Daptacel Drugs 0.000 claims 1
- 229940124884 Engerix-B Drugs 0.000 claims 1
- 241000710781 Flaviviridae Species 0.000 claims 1
- 229940124895 FluMist Drugs 0.000 claims 1
- 229940124896 Fluarix Drugs 0.000 claims 1
- 229940124893 Fluvirin Drugs 0.000 claims 1
- 229940124894 Fluzone Drugs 0.000 claims 1
- 229940124897 Gardasil Drugs 0.000 claims 1
- 229940124914 Havrix Drugs 0.000 claims 1
- 241000700586 Herpesviridae Species 0.000 claims 1
- 229940124913 IPOL Drugs 0.000 claims 1
- 229940124915 Infanrix Drugs 0.000 claims 1
- 229940124956 Ixiaro Drugs 0.000 claims 1
- 229940124918 JE-Vax Drugs 0.000 claims 1
- 229940124919 Kinrix Drugs 0.000 claims 1
- GXCLGNHLZMTTQJ-ZOULSWATSA-N L-alpha-D-Hepp-(1->3)-L-alpha-D-Hepp Chemical compound O[C@@H]1[C@@H]([C@@H](O)CO)O[C@H](O)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H]([C@@H](O)CO)O1 GXCLGNHLZMTTQJ-ZOULSWATSA-N 0.000 claims 1
- 241000712079 Measles morbillivirus Species 0.000 claims 1
- 229940124904 Menactra Drugs 0.000 claims 1
- 241000711386 Mumps virus Species 0.000 claims 1
- 241000588653 Neisseria Species 0.000 claims 1
- 241000588650 Neisseria meningitidis Species 0.000 claims 1
- 241000712464 Orthomyxoviridae Species 0.000 claims 1
- 241000711504 Paramyxoviridae Species 0.000 claims 1
- 229940124908 Pediarix Drugs 0.000 claims 1
- 101100338762 Pedobacter heparinus (strain ATCC 13125 / DSM 2366 / CIP 104194 / JCM 7457 / NBRC 12017 / NCIMB 9290 / NRRL B-14731 / HIM 762-3) hepB gene Proteins 0.000 claims 1
- 229940124909 PedvaxHIB Drugs 0.000 claims 1
- 229940124910 Pentacel Drugs 0.000 claims 1
- 201000005702 Pertussis Diseases 0.000 claims 1
- 229940124876 ProQuad Drugs 0.000 claims 1
- 229940124875 RabAvert Drugs 0.000 claims 1
- 241000711798 Rabies lyssavirus Species 0.000 claims 1
- 241000702263 Reovirus sp. Species 0.000 claims 1
- 241000725643 Respiratory syncytial virus Species 0.000 claims 1
- 241000712907 Retroviridae Species 0.000 claims 1
- 241000711931 Rhabdoviridae Species 0.000 claims 1
- 229940124878 RotaTeq Drugs 0.000 claims 1
- 229940124941 Rotarix Drugs 0.000 claims 1
- 241000702670 Rotavirus Species 0.000 claims 1
- 241000710799 Rubella virus Species 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 229940124929 TYPHIM Vi Drugs 0.000 claims 1
- 241000710924 Togaviridae Species 0.000 claims 1
- 229940124923 Tripedia Drugs 0.000 claims 1
- 229940124922 Twinrix Drugs 0.000 claims 1
- 206010046865 Vaccinia virus infection Diseases 0.000 claims 1
- 229940124937 Vaqta Drugs 0.000 claims 1
- 206010046980 Varicella Diseases 0.000 claims 1
- 229940124924 Varivax Drugs 0.000 claims 1
- 229940124928 YF-Vax Drugs 0.000 claims 1
- 241000710772 Yellow fever virus Species 0.000 claims 1
- 229940124925 Zostavax Drugs 0.000 claims 1
- 229940102614 adacel Drugs 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 229960003983 diphtheria toxoid Drugs 0.000 claims 1
- 229960005097 diphtheria vaccines Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 230000005684 electric field Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 229940047650 haemophilus influenzae Drugs 0.000 claims 1
- 229940045808 haemophilus influenzae type b Drugs 0.000 claims 1
- 229960004443 hemophilus influenzae b vaccines Drugs 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 229940026063 imovax Drugs 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 229940014135 meningitis vaccine Drugs 0.000 claims 1
- 229940049548 pneumovax Drugs 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 229940114241 recombivax Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 150000008163 sugars Chemical group 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 229960000814 tetanus toxoid Drugs 0.000 claims 1
- 229960002766 tetanus vaccines Drugs 0.000 claims 1
- 201000008827 tuberculosis Diseases 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
- 208000007089 vaccinia Diseases 0.000 claims 1
- 229940021648 varicella vaccine Drugs 0.000 claims 1
- 229960001515 yellow fever vaccine Drugs 0.000 claims 1
- 229940051021 yellow-fever virus Drugs 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000028993 immune response Effects 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229940124590 live attenuated vaccine Drugs 0.000 description 1
- 229940023012 live-attenuated vaccine Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229960002109 tuberculosis vaccine Drugs 0.000 description 1
- 244000000057 wild-type pathogen Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161477737P | 2011-04-21 | 2011-04-21 | |
| US61/477,737 | 2011-04-21 | ||
| PCT/US2012/034643 WO2012145739A1 (en) | 2011-04-21 | 2012-04-23 | Compositions and methods for stabilization of active agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017042342A Division JP2017137328A (ja) | 2011-04-21 | 2017-03-07 | 活性物質を安定化させるための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014518557A JP2014518557A (ja) | 2014-07-31 |
| JP2014518557A5 true JP2014518557A5 (enExample) | 2016-09-29 |
| JP6170906B2 JP6170906B2 (ja) | 2017-07-26 |
Family
ID=47041958
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014506615A Active JP6170906B2 (ja) | 2011-04-21 | 2012-04-23 | 活性物質を安定化させるための組成物および方法 |
| JP2017042342A Pending JP2017137328A (ja) | 2011-04-21 | 2017-03-07 | 活性物質を安定化させるための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017042342A Pending JP2017137328A (ja) | 2011-04-21 | 2017-03-07 | 活性物質を安定化させるための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20140287043A1 (enExample) |
| EP (1) | EP2699266B1 (enExample) |
| JP (2) | JP6170906B2 (enExample) |
| CN (2) | CN105148285B (enExample) |
| AU (6) | AU2012245198B2 (enExample) |
| BR (1) | BR112013027057A2 (enExample) |
| CA (1) | CA2833879C (enExample) |
| IL (1) | IL228984A0 (enExample) |
| WO (1) | WO2012145739A1 (enExample) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102271724B (zh) | 2008-10-09 | 2015-10-14 | 塔夫茨大学信托人 | 含有甘油的改性丝膜 |
| US20140287043A1 (en) | 2011-04-21 | 2014-09-25 | Trustees Of Tufts College | Compositions and methods for stabilization of active agents |
| WO2013106822A1 (en) | 2012-01-12 | 2013-07-18 | Johnson Jed K | Nanofiber scaffolds for biological structures |
| JP2015510818A (ja) | 2012-03-20 | 2015-04-13 | トラスティーズ オブ タフツ カレッジ | 薬物送達のための絹リザーバー |
| WO2013155404A1 (en) | 2012-04-13 | 2013-10-17 | Trustees Of Tufts College | Methods and compositions for preparing a silk microsphere |
| US10653786B2 (en) | 2012-04-25 | 2020-05-19 | Trustees Of Tufts College | Silk microspheres and methods for surface lubrication |
| WO2014127309A1 (en) | 2013-02-15 | 2014-08-21 | Tufts University | Silk-based nanoimprinting |
| US11376329B2 (en) | 2013-03-15 | 2022-07-05 | Trustees Of Tufts College | Low molecular weight silk compositions and stabilizing silk compositions |
| WO2014197093A2 (en) | 2013-03-15 | 2014-12-11 | Tufts University | All water-based nanopatterning |
| AU2014233480B2 (en) * | 2013-03-15 | 2018-08-09 | Trustees Of Tufts College | Low molecular weight silk compositions and stabilizing silk compositions |
| AU2014240170B2 (en) * | 2013-03-15 | 2018-05-17 | Patheon Softgels Inc. | Silk-based capsules |
| WO2014144971A1 (en) | 2013-03-15 | 2014-09-18 | Tufts University | Silk water lithography |
| ITMI20131255A1 (it) * | 2013-07-26 | 2015-01-27 | Ct Tessile Serico Societa Co Nsortile Per A | Composizioni farmaceutiche nebulizzabili a base di fibroina per il trattamento di lesioni cutanee |
| CN105579059B (zh) * | 2013-09-03 | 2020-07-31 | 佐治亚科技研究公司 | 热稳定的疫苗配制物、工艺和包含疫苗配制物的微针 |
| CA2923753C (en) | 2013-09-19 | 2021-10-12 | Terumo Corporation | Polymer particles |
| BR112016005768B1 (pt) * | 2013-09-19 | 2021-09-21 | Microvention, Inc | Películas de polímero |
| KR20210153142A (ko) * | 2013-09-30 | 2021-12-16 | 실크 테라퓨틱스, 인코퍼레이티드 | 실크 단백질 단편 조성물 및 이로부터 제작된 물품 |
| EP3065719A4 (en) | 2013-11-08 | 2017-08-09 | Terumo Corporation | Polymer particles |
| ES2875330T3 (es) * | 2014-04-04 | 2021-11-10 | Nanofiber Solutions Llc | Composiciones de fibras biocompatibles electrohiladas |
| EA035551B1 (ru) | 2014-12-02 | 2020-07-06 | Силк Терапьютикс, Инк. | Изделие |
| US10213378B2 (en) * | 2015-03-10 | 2019-02-26 | Sporos Therapeutics, LLC | Single dose non-adjuvanted cutaneous tetanus vaccine and uses thereof |
| US9907880B2 (en) | 2015-03-26 | 2018-03-06 | Microvention, Inc. | Particles |
| CN104940981B (zh) * | 2015-05-21 | 2018-11-30 | 重庆市畜牧科学院 | 具有生物活性的外用敷料及其制备方法 |
| CN108135975A (zh) | 2015-07-14 | 2018-06-08 | 丝绸医疗公司 | 丝性能服装和产品及其制备方法 |
| CN105903027A (zh) * | 2016-05-31 | 2016-08-31 | 福建傲农生物科技集团股份有限公司 | 一种常温下长期保存抗生素的方法 |
| WO2017214187A1 (en) * | 2016-06-07 | 2017-12-14 | Aridis Pharmaceuticals, Inc. | Method for preparation of quick dissolving thin films containing bioactive material with enhanced thermal stability |
| CN106362223B (zh) * | 2016-08-26 | 2019-05-03 | 南通纺织丝绸产业技术研究院 | 多孔丝素蛋白微针给药装置及其制备方法 |
| GB201614799D0 (en) * | 2016-09-01 | 2016-10-19 | Glaxosmithkline Biologicals Sa | Compositions |
| US20190275136A1 (en) * | 2016-09-19 | 2019-09-12 | Vaxess Technologies, Inc. | Vaccine formulations with increased stability |
| CA3038642C (en) | 2016-09-28 | 2021-11-02 | Terumo Corporation | Polymer particles comprising polymerizable pharmaceutical agents |
| US10857262B2 (en) | 2016-10-31 | 2020-12-08 | Sofregen Medical, Inc. | Compositions comprising low molecular weight silk fibroin fragments and plasticizers |
| US10898608B2 (en) | 2017-02-02 | 2021-01-26 | Nanofiber Solutions, Llc | Methods of improving bone-soft tissue healing using electrospun fibers |
| US11390988B2 (en) | 2017-09-27 | 2022-07-19 | Evolved By Nature, Inc. | Silk coated fabrics and products and methods of preparing the same |
| WO2019094702A1 (en) | 2017-11-10 | 2019-05-16 | Cocoon Biotech Inc. | Ocular applications of silk-based products |
| SG11202007503WA (en) * | 2018-02-07 | 2020-09-29 | Bharat Biotech Int Ltd | A process for enterovirus purification and inactivation and vaccine compositions obtained thereof |
| EP3830576A2 (en) * | 2018-07-27 | 2021-06-09 | Vaxess Technologies, Inc. | Polymer-based biospecimen collection devices and uses thereof |
| CA3111273C (en) * | 2018-09-06 | 2024-03-26 | Bavarian Nordic A/S | Storage improved poxvirus compositions |
| MX2021006436A (es) | 2018-12-10 | 2021-09-14 | Cambridge Crops Inc | Composiciones y metodos para la extension de la vida util a base de polimero. |
| TWI691531B (zh) * | 2019-02-11 | 2020-04-21 | 南臺學校財團法人南臺科技大學 | 蠶絲蛋白膜的製造方法 |
| AU2020288624B2 (en) | 2019-06-04 | 2025-09-25 | Cocoon Biotech Inc. | Silk-based products, formulations, and methods of use |
| CN110627899A (zh) * | 2019-10-09 | 2019-12-31 | 山东天牧生物科技有限公司 | 一种呼肠孤病毒和细小病毒卵黄抗体锭及其制备方法 |
| WO2021076798A1 (en) | 2019-10-15 | 2021-04-22 | Sofregen Medical, Inc. | Delivery devices for delivering and methods of delivering compositions |
| US20220409484A1 (en) * | 2019-11-18 | 2022-12-29 | Elanco Us Inc. | Lyophilized cake in straight-walled vial |
| US20230285536A1 (en) * | 2020-06-24 | 2023-09-14 | Trustees Of Tufts College | Edible cell based vaccines |
| WO2022101877A1 (pt) * | 2020-11-13 | 2022-05-19 | Targetalent, Lda | Composição de criopreservação de amostras biológicas para pcr |
| WO2022109294A2 (en) * | 2020-11-20 | 2022-05-27 | Team Medical Llc | Rna stabilization |
| US20240117321A1 (en) * | 2021-03-02 | 2024-04-11 | Georgia Tech Research Corporation | Hydrogel materials and methods of making and transport using the same |
| US11976196B2 (en) | 2021-04-14 | 2024-05-07 | Cambridge Crops, Inc. | Silk packaging applications |
| US11584784B2 (en) | 2021-05-21 | 2023-02-21 | Cambridge Crops, Inc. | Systems and methods for manufacturing a silk fibroin solution and powders containing silk fibroin |
| US11864569B2 (en) | 2021-08-16 | 2024-01-09 | Cambridge Crops, Inc. | Systems and methods for improving the performance of cereal using a silk fibroin solution and powders containing silk fibroin |
| CN116421734A (zh) * | 2021-12-30 | 2023-07-14 | 深圳复诺健生物科技有限公司 | 适用于溶瘤病毒的冻干保护剂及其应用 |
| US20250223571A1 (en) | 2022-03-30 | 2025-07-10 | Bioneedle Drug Delivery B.V. | A process for storing biologically active constructs in a biodegradable material |
| CN115227863A (zh) * | 2022-07-01 | 2022-10-25 | 浙江大学 | 一种搭载噬菌体的复合水凝胶及其制备方法 |
| EP4613287A1 (en) * | 2022-10-31 | 2025-09-10 | National Agriculture And Food Research Organization | Oral-administration-type vaccine composition containing fibroin-containing nanoparticles |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8808A (en) | 1852-03-16 | Planiwg-machiete | ||
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3832253A (en) | 1973-03-21 | 1974-08-27 | Baxter Laboratories Inc | Method of making an inflatable balloon catheter |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4667014A (en) | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| CA1200416A (en) | 1983-05-13 | 1986-02-11 | Societe Des Produits Nestle S.A. | Food process |
| JPH0652268B2 (ja) * | 1985-07-03 | 1994-07-06 | 鐘紡株式会社 | 固定化抗原 |
| CN86100565A (zh) * | 1986-04-30 | 1987-11-11 | 华东化工学院 | 一种共价活化的固定化酶载体 |
| JPH07121871B2 (ja) * | 1986-10-09 | 1995-12-25 | 国立予防衛生研究所長 | インフルエンザワクチン凍結乾燥製剤 |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| IE61575B1 (en) | 1987-05-04 | 1994-11-16 | Merck & Co Inc | A stable lyophilized live herpes virus vaccine |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| JP2750306B2 (ja) * | 1989-05-24 | 1998-05-13 | ポーラ化成工業株式会社 | 固定化低分子プロテインａの製造法 |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5245012A (en) | 1990-04-19 | 1993-09-14 | The United States Of America As Represented By The Secretary Of The Army | Method to achieve solubilization of spider silk proteins |
| JPH04167172A (ja) | 1990-10-31 | 1992-06-15 | Nec Corp | ベクトルプロセッサ |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5346481A (en) | 1993-10-14 | 1994-09-13 | Merck & Co., Inc. | Vaccine delivery system |
| US5900238A (en) | 1995-07-27 | 1999-05-04 | Immunex Corporation | Vaccine delivery system |
| IL123398A0 (en) | 1995-08-22 | 1998-09-24 | Agricola Tech Inc | Cloning methods for high strength spider silk proteins |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US5797898A (en) | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
| AU725231B2 (en) | 1996-12-20 | 2000-10-12 | Merck & Co., Inc. | Stabilisers for lyophilised vaccines |
| JP3101711B2 (ja) * | 1997-11-20 | 2000-10-23 | 農林水産省蚕糸・昆虫農業技術研究所長 | 生体高分子からなる吸着体／徐放体及びその製造方法 |
| WO2001012157A1 (en) | 1999-08-18 | 2001-02-22 | Microchips, Inc. | Thermally-activated microchip chemical delivery devices |
| EP1690527B1 (en) | 1999-11-17 | 2015-01-07 | Boston Scientific Limited | Microfabricated devices for the delivery of molecules into a carrier fluid |
| EP1372602B1 (en) | 2001-01-09 | 2007-04-18 | Microchips, Inc. | Flexible microchip devices for ophthalmic and other applications |
| GB0109297D0 (en) * | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
| US20020193729A1 (en) | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
| RU21271U1 (ru) * | 2001-08-06 | 2002-01-10 | Алкацева Надежда Ильинична | Основа для косметических средств |
| AR040819A1 (es) | 2002-08-08 | 2005-04-20 | Alza Corp | Dispositivo de administracion transdermica de vacuna que tiene microproyecciones revestidas |
| JP2005097229A (ja) * | 2002-12-04 | 2005-04-14 | Toray Ind Inc | ワクチンおよび抗原タンパク質の製造方法 |
| WO2004062697A2 (en) | 2003-01-07 | 2004-07-29 | Tufts University | Silk fibroin materials and use thereof |
| US7060260B2 (en) * | 2003-02-20 | 2006-06-13 | E.I. Du Pont De Nemours And Company | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring |
| EP1613796B1 (en) | 2003-04-10 | 2017-03-22 | Tufts University | Concentrated aqueous silk fibroin solution and use thereof |
| US20050123550A1 (en) * | 2003-05-12 | 2005-06-09 | Laurent Philippe E. | Molecules enhancing dermal delivery of influenza vaccines |
| US7588774B2 (en) * | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
| US20050123565A1 (en) | 2003-10-31 | 2005-06-09 | Janardhanan Subramony | System and method for transdermal vaccine delivery |
| JP2007518468A (ja) | 2003-11-21 | 2007-07-12 | アルザ・コーポレーシヨン | 超音波支援経皮ワクチン送達方法およびシステム |
| CN1243059C (zh) * | 2004-03-04 | 2006-02-22 | 苏州大学 | 纳米丝素颗粒的制造方法 |
| GB0405787D0 (en) * | 2004-03-15 | 2004-04-21 | Chiron Srl | Low dose vaccines |
| WO2006062685A2 (en) | 2004-11-11 | 2006-06-15 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
| US7960509B2 (en) | 2005-01-14 | 2011-06-14 | Trustees Of Tufts College | Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials |
| CA2645934C (en) * | 2005-08-02 | 2014-04-29 | Trustees Of Tufts College | Methods for stepwise deposition of silk fibroin coatings |
| US20090182306A1 (en) * | 2006-07-21 | 2009-07-16 | Georgia Tech Research Corporation | Microneedle Devices and Methods of Drug Delivery or Fluid Withdrawal |
| US20100028451A1 (en) | 2006-09-26 | 2010-02-04 | Trustees Of Tufts College | Silk microspheres for encapsulation and controlled release |
| CA2704768A1 (en) * | 2006-11-03 | 2008-10-23 | Trustees Of Tufts College | Biopolymer sensor and method of manufacturing the same |
| WO2008127401A2 (en) | 2006-11-03 | 2008-10-23 | Trustees Of Tufts College | Biopolymer optical waveguide and method of manufacturing the same |
| DK2211876T3 (en) | 2007-05-29 | 2015-01-12 | Tufts College | PROCESS FOR silk fibroin-GELATION USING sonication |
| WO2009048607A1 (en) * | 2007-10-10 | 2009-04-16 | Corium International, Inc. | Vaccine delivery via microneedle arrays |
| CN101925675A (zh) * | 2007-11-28 | 2010-12-22 | 器官发生有限公司 | 生物工程化组织构建物及其制备和使用方法 |
| US8206774B2 (en) | 2008-03-13 | 2012-06-26 | Trustees Of Tufts College | Diazonium salt modification of silk polymer |
| US8501172B2 (en) | 2008-09-26 | 2013-08-06 | Trustees Of Tufts College | pH-induced silk gels and uses thereof |
| CN102271724B (zh) | 2008-10-09 | 2015-10-14 | 塔夫茨大学信托人 | 含有甘油的改性丝膜 |
| WO2010057142A2 (en) | 2008-11-17 | 2010-05-20 | Trustees Of Tufts College | Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti adhesion barriers and anti thrombotic materials |
| CA2791580C (en) | 2009-03-04 | 2017-12-05 | Trustees Of Tufts College | Silk fibroin systems for antibiotic delivery |
| WO2011005381A2 (en) | 2009-06-01 | 2011-01-13 | Trustees Of Tufts College | Vortex-induced silk fibroin gelation for encapsulation and delivery |
| US8293486B2 (en) | 2009-07-21 | 2012-10-23 | Trustees Of Tufts College | Functionalization of silk material by avidin-biotin interaction |
| EP2483199B1 (en) | 2009-09-29 | 2017-04-26 | Trustees Of Tufts College | Silk nanospheres and microspheres and methods of making same |
| AU2011317107B2 (en) * | 2010-10-19 | 2016-02-25 | Trustees Of Tufts College | Silk fibroin-based microneedles and methods of making the same |
| CN102085173B (zh) * | 2011-01-26 | 2012-05-30 | 上海交通大学 | 以天然蚕丝蛋白为乳化剂的生物活性乳液及其制备方法 |
| US20140287043A1 (en) | 2011-04-21 | 2014-09-25 | Trustees Of Tufts College | Compositions and methods for stabilization of active agents |
-
2012
- 2012-04-23 US US14/112,769 patent/US20140287043A1/en not_active Abandoned
- 2012-04-23 CN CN201510559840.6A patent/CN105148285B/zh active Active
- 2012-04-23 AU AU2012245198A patent/AU2012245198B2/en active Active
- 2012-04-23 CN CN201280030582.7A patent/CN103796683A/zh active Pending
- 2012-04-23 BR BR112013027057-8A patent/BR112013027057A2/pt not_active IP Right Cessation
- 2012-04-23 JP JP2014506615A patent/JP6170906B2/ja active Active
- 2012-04-23 EP EP12774253.4A patent/EP2699266B1/en active Active
- 2012-04-23 CA CA2833879A patent/CA2833879C/en active Active
- 2012-04-23 WO PCT/US2012/034643 patent/WO2012145739A1/en not_active Ceased
-
2013
- 2013-10-21 IL IL228984A patent/IL228984A0/en unknown
-
2017
- 2017-03-07 JP JP2017042342A patent/JP2017137328A/ja active Pending
- 2017-04-20 US US15/492,363 patent/US20170258889A1/en not_active Abandoned
- 2017-06-20 AU AU2017204162A patent/AU2017204162A1/en not_active Abandoned
- 2017-12-29 US US15/858,239 patent/US12280101B2/en active Active
-
2018
- 2018-09-03 AU AU2018226377A patent/AU2018226377B2/en active Active
-
2020
- 2020-05-18 AU AU2020203212A patent/AU2020203212A1/en not_active Abandoned
- 2020-08-13 AU AU2020217419A patent/AU2020217419A1/en not_active Abandoned
-
2022
- 2022-09-20 AU AU2022235540A patent/AU2022235540A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014518557A5 (enExample) | ||
| Cimica et al. | Adjuvant formulations for virus-like particle (VLP) based vaccines | |
| US8551451B2 (en) | Combination vaccine with acellular pertussis | |
| JP7063957B2 (ja) | エンテロウイルス不活化およびアジュバント吸着のための改良された方法、ならびに、それから得られる投与量減量ワクチン組成物 | |
| HRP20110431T1 (hr) | Kombinirano cjepivo od inaktiviranog poliovirusa | |
| HRP20250077T1 (hr) | Nove imunogene formulacije koje sadrže ravne ili razgranate polimerne adjuvante poliakrilne kiseline | |
| Hudu et al. | An overview of recombinant vaccine technology, adjuvants and vaccine delivery methods | |
| RU2016150422A (ru) | Комбинированная семивалентная вакцина | |
| US20110195087A1 (en) | Combination vaccine with whole cell pertussis | |
| KR20180096829A (ko) | 동결건조하지 않는 인플루엔자 백신 항원의 농축 | |
| JP2017533899A5 (enExample) | ||
| CN1062770C (zh) | 甲肝-麻疹二联疫苗及其生产方法 | |
| WO2017044932A1 (en) | Multivalent vlp conjugates | |
| RS20070078A (sr) | Inaktivirana vakcina protiv poliomijelitisa nastala iz sabinovog soja polio virusa | |
| JPWO2020037285A5 (enExample) | ||
| BR112021006707A2 (pt) | composição de vacina de combinação que compreende o vírus da poliomielite inativado em dose reduzida e método para preparação da mesma | |
| WO2018037365A8 (en) | Multivalent vaccine composition | |
| Domachowske | Active immunization | |
| US11793869B2 (en) | Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof | |
| CN121081616A (zh) | 山羊痘绵羊痘疫苗及其制备方法 | |
| MM et al. | Efficacy of Carbomer as a Stabilizer for Lyophilized attenuated Peste des Petits Ruminants (PPR) vaccine | |
| Božić et al. | An overview of current vacccines for the prophylaxis of bacterical infections Pres | |
| TWI711700B (zh) | 使腸病毒去活化之改良方法、佐劑吸附及所獲得之劑量減少的疫苗組成物 | |
| CN104353068A (zh) | 一种利用人二倍体细胞大规模生产狂犬疫苗的方法 | |
| IMB | Vaccines authorised and marketed in Ireland |